Company Information

HEMANT SURGICAL INDUSTRIES LTD.

NSE : NABSE : 543916ISIN CODE : INE0GYI01028Industry : Medical Equipment/Supplies/AccessoriesHouse : Private
BSE139.85-0.15 (-0.11 %)
PREV CLOSE ( ) 140.00
OPEN PRICE ( ) 140.45
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 7200
TODAY'S LOW / HIGH ( )139.50 140.50
52 WK LOW / HIGH ( ) 121260
NSE
This Company is not listed in NSE
ChairmanHanskumar Shamji Shah
Managing DirectorHanskumar Shamji Shah
Company SecretaryMeenal Ajmera
Non Executive DirectorNehal Babu Karelia
Non Executive Independent DirectorPooja Kothari
Sourabh Ajmera
Whole Time DirectorHemant Praful Shah
Kaushik Shah
Incorporation Year : 27-03 1989

Registered Office :

Address : 502,5th Floor, Ecstasy Business Park,Co-op Socteiy Limited, J. S. D. Road,Mulund West Mumbai,
Maharashtra-400080 .

Phone : 022-25915289 / 25912747

Email :  cs@hemantsurgical.com 

Industry : Medical Equipment/Supplies/Accessories

Listing : BSE

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.